SynCardia
SynCardia Systems, LLC, a Picard Medical Company, offers the SynCardia Total Artificial Heart, a treatment for cardiac transplant-eligible patients with biventricular failure.
SynCardia Services
SynCardia offers the SynCardia Total Artificial Heart, a treatment option specifically designed for cardiac transplant-eligible patients who face imminent death due to biventricular failure. The Total Artificial Heart serves as a temporary heart, providing a bridge for patients waiting for a heart transplant, particularly when a donor heart is not immediately available. This innovative solution is vital for ensuring patients remain stable until transplantation.
SynCardia Products
The main product offered by SynCardia is the SynCardia Total Artificial Heart. The Total Artificial Heart is available in two sizes—50cc and 70cc—to accommodate the majority of patients' anatomical needs. This product is crucial for providing lifesaving support to patients experiencing severe heart failure. Additionally, SynCardia holds a trademark for 'Freedom', though specific details on products related to this trademark are not provided.
SynCardia Company History
SynCardia Systems, LLC, a Picard Medical Company, has implanted over 2,000 SynCardia Total Artificial Hearts in more than 20 countries globally. Located at 1992 E. Silverlake Rd., Tucson, AZ 85713, the company has achieved significant milestones in the development and deployment of artificial heart technologies. Recently, the U.S. Patent and Trademark Office granted SynCardia a patent for its next-generation total artificial heart designs, further establishing its role in advancing cardiac care solutions.
SynCardia Sector Overview
SynCardia operates within the medical device sector, particularly focusing on cardiac care solutions. Its primary offering, the SynCardia Total Artificial Heart, addresses critical needs for patients with severe heart conditions requiring a bridge to heart transplantation. This focus on innovative cardiac devices plays a significant role in enhancing patient outcomes within the healthcare industry.